Regulatory
FDA Approves Lantheus’s Tauklarify, a Brain-Scan Agent That Maps Alzheimer’s Tau Tangles
The radiodiagnostic lets PET scans visualize tau neurofibrillary tangles — a core hallmark of Alzheimer’s — complementing existing amyloid imaging in patients being evaluated for the disease.